Company: LPSN
Filing Date: 2025-08-13
Form Type: 10-Q
Source: 0001102993-25-000108
Chunk: 90

Company: LIVEPERSON INC
Filing Date: 2025-08-13
Form: 10-Q
Item: Part I, Item 8
Chunk 90
---
-K for the year ended December 31, 2024. There have been no significant changes to these policies that have had a material impact on the Company’s condensed consolidated financial statements and related notes for the three and six months ended June 30, 2025.Prepaid expenses and other current assetsThe following table presents the detail of prepaid expenses and other current assets as of the dates presented:June 30,2025December 31,2024(In thousands)Prepaid software maintenance$11,726 $9,868 VAT receivable2,813 2,452 Other prepaid expenses1,627 2,910 Other current assets29,165 4,020 Total prepaid expenses and other current assets$45,331 $19,250 LeasesThe Company has non-cancelable operating and finance leases for its corporate offices and other service agreements. As of June 30, 2025, the Company’s leases are immaterial, with a remaining lease term of 0.9 years with an option to extend. The Company uses the non-cancelable lease term when recognizing the right-of-use assets and lease liabilities, unless it is reasonably certain that a renewal or termination option will be exercised. The Company’s operating lease costs were $2.5 million and $2.6 million for the three months ended June 30, 2025 and 2024, respectively. The Company’s operating lease costs were $4.9 million and $5.5 million for the six months ended June 30, 2025 and 2024, respectively. DivestituresIn the second quarter of 2024, the Company completed the sale of 100% of the equity in WildHealth to a third party. Pursuant to Accounting Standards Codification (“ASC”) Subtopic 205-20, Presentation of Financial Statements - Discontinued Operations, the divestiture did not meet the criteria for presentation as a discontinued operation. WildHealth was part of the Business segment and was a separate reporting unit. The transaction resulted in a loss of $0.6 million which was recognized and presented separately in Loss on divestiture on the Company’s consolidated statements of operations for the year ended December 31, 2024. Subsequent to the closing, the Company does not have ongoing involvement or arrangements with WildHealth.     

11

NOTES TO CONDENSED CONSOLIDATED FINANCIAL STATEMENTS(UNAUDITED)

Recently Issued Accounting PronouncementsIn